2008
DOI: 10.1016/j.gie.2008.03.522
|View full text |Cite
|
Sign up to set email alerts
|

Contrast-Enhanced Endoscopic Ultrasonography (CE-EUS) in Solid Tumors of the Pancreas: Results of a Pilot Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

1
1
0

Year Published

2010
2010
2010
2010

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
1
1
0
Order By: Relevance
“…In some studies this pattern was considered a predictive factor for malignancy [19,20]. It differentiated adenocarcinoma from hyperenhanced neuroendocrine tumors [18], although a hyperenhanced pattern of pancreatic adenocarcinoma was also reported, as also seen in our group [21,22]. In our study, a qualitative visual hypoenhanced pattern after contrast medium injection could not differentiate between a benign mass of chronic pancreatitis and adenocarcinoma in contrast to another study on 38 patients which considered a hypoenhanced appearance to be the only variable predictive of malignancy in focal pancreatic solid lesions [19].…”
supporting
confidence: 75%
See 1 more Smart Citation
“…In some studies this pattern was considered a predictive factor for malignancy [19,20]. It differentiated adenocarcinoma from hyperenhanced neuroendocrine tumors [18], although a hyperenhanced pattern of pancreatic adenocarcinoma was also reported, as also seen in our group [21,22]. In our study, a qualitative visual hypoenhanced pattern after contrast medium injection could not differentiate between a benign mass of chronic pancreatitis and adenocarcinoma in contrast to another study on 38 patients which considered a hypoenhanced appearance to be the only variable predictive of malignancy in focal pancreatic solid lesions [19].…”
supporting
confidence: 75%
“…The hypoenhanced inhomogeneous pattern was seen more frequently in the chronic pancreatitis group (6 /12), but was also seen in the adenocarcinoma group (4 /15). Some other authors confirm this [22]. Indeed, another study has reported heterogeneous enhancement in three of four cases of adenocarcinoma, but in none of three patients with chronic pancreatitis [18].…”
mentioning
confidence: 68%